サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1693151

デュアルオレキシン受容体拮抗薬の世界市場の考察、予測（～2031年）

Global Dual Orexin Receptor Antagonist Market Insights, Forecast to 2031

出版日
発行
QYResearch
ページ情報
英文 114 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
デュアルオレキシン受容体拮抗薬の世界市場の考察、予測（～2031年）
出版日: 2025年04月01日
発行: QYResearch
ページ情報: 英文 114 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のデュアルオレキシン受容体拮抗薬の市場規模は、2024年の6億7,085万米ドルから2031年までに12億3,497万米ドルに達すると予測され、予測期間にCAGRで7.14%の成長が見込まれます。

米国・カナダの市場規模は、2024年の1億4,576万米ドルから2031年までに1億6,232万米ドルに達すると推定され、2025年～2031年の予測期間のCAGRは0.61%です。

日本の市場規模は、2024年の4億3,187万米ドルから2031年までに7億711万米ドルに達すると推定され、2025年～2031年の予測期間のCAGRは5.18%です。

欧州の市場規模は、2024年の7,935万米ドルから2031年までに3億4,307万米ドルに達すると推定され、2025年～2031年の予測期間のCAGRは18.23%です。

世界のデュアルオレキシン受容体拮抗薬の主要メーカーは、Merck、Eisal、Idorsiaなどです。2024年、世界の上位2社の収益シェアは約83.43%でした。

当レポートでは、世界のデュアルオレキシン受容体拮抗薬市場について調査分析し、各地域の市場規模と予測、主要企業のランキング、市場シェアなどの情報を提供しています。

目次

第1章 調査範囲

  • デュアルオレキシン受容体拮抗薬製品のイントロダクション
  • 市場：タイプ別
    • 世界のデュアルオレキシン受容体拮抗薬の市場規模成長率：タイプ別（2020年・2024年・2031年）
    • スボレキサント
    • レンボレキサント
    • ダリドレキサント
  • 市場：用途別
    • 世界のデュアルオレキシン受容体拮抗薬の市場規模成長率：用途別（2020年・2024年・2031年）
    • 病院、診療所
    • 小売薬局
    • その他
  • 前提条件と制限
  • 調査目的
  • 考慮される年数

第2章 エグゼクティブサマリー

  • 世界のデュアルオレキシン受容体拮抗薬の収益の推計と予測（2020年～2031年）
  • 世界の収益：地域別
    • 世界のデュアルオレキシン受容体拮抗薬の収益：地域別（2020年・2024年・2031年）
    • 世界のデュアルオレキシン受容体拮抗薬の収益：地域別（2020年～2031年）
    • 世界のデュアルオレキシン受容体拮抗薬の収益の市場シェア：地域別（2020年～2031年）
  • 世界の～2031年のデュアルオレキシン受容体拮抗薬の売上の推計と予測（2020年）
  • 世界の売上：地域別
    • 世界のデュアルオレキシン受容体拮抗薬の売上：地域別（2020年・2024年・2031年）
    • 世界のデュアルオレキシン受容体拮抗薬の売上：地域別（2020年～2031年）
    • 世界のデュアルオレキシン受容体拮抗薬の売上の市場シェア：地域別（2020年～2031年）
  • 米国・カナダ
  • 欧州
  • 日本
  • その他の地域

第3章 各メーカーの競合

  • 世界の売上：メーカー別
    • 世界のデュアルオレキシン受容体拮抗薬の売上：メーカー別（2020年～2025年）
    • 世界のデュアルオレキシン受容体拮抗薬の市場シェア：メーカー別（2020年～2025年）
    • 世界のデュアルオレキシン受容体拮抗薬の3大メーカー（2024年）
  • 世界の収益：メーカー別
    • 世界のデュアルオレキシン受容体拮抗薬の収益：メーカー別（2020年～2025年）
    • 世界のデュアルオレキシン受容体拮抗薬の収益の市場シェア：メーカー別（2020年～2025年）
    • 世界のデュアルオレキシン受容体拮抗薬収益の上位2社（2024年）
  • 世界のデュアルオレキシン受容体拮抗薬の主要企業、業界ランキング（2023年・2024年）
  • 世界のデュアルオレキシン受容体拮抗薬の販売価格：メーカー別（2020年～2025年）
  • 競合情勢の分析
    • メーカーの市場集中度（CR3、HHI）
    • 世界のデュアルオレキシン受容体拮抗薬市場のシェア：企業タイプ別（Tier 1・Tier 2・Tier 3）
  • 世界のデュアルオレキシン受容体拮抗薬の主要メーカー、製造拠点の分布、本社
  • 世界のデュアルオレキシン受容体拮抗薬の主要メーカー、製品と用途
  • 世界のデュアルオレキシン受容体拮抗薬の主要メーカー、業界参入日
  • 合併と買収、拡張計画

第4章 市場規模：タイプ別

  • 世界の売上：タイプ別
    • 世界のデュアルオレキシン受容体拮抗薬の売上の実績：タイプ別（2020年～2025年）
    • 世界のデュアルオレキシン受容体拮抗薬の売上の予測：タイプ別（2026年～2031年）
    • 世界のデュアルオレキシン受容体拮抗薬の売上の市場シェア：タイプ別（2020年～2031年）
  • 世界の収益：タイプ別
    • 世界のデュアルオレキシン受容体拮抗薬の収益の実績：タイプ別（2020年～2025年）
    • 世界のデュアルオレキシン受容体拮抗薬の収益の予測：タイプ別（2026年～2031年）
    • 世界のデュアルオレキシン受容体拮抗薬の収益の市場シェア：タイプ別（2020年～2031年）
  • 世界の価格：タイプ別
    • 世界のデュアルオレキシン受容体拮抗薬の価格：タイプ別（2020年～2025年）
    • 世界のデュアルオレキシン受容体拮抗薬の価格の予測：タイプ別（2026年～2031年）

第5章 市場規模：用途別

  • 世界の売上：用途別
    • 世界のデュアルオレキシン受容体拮抗薬の売上の実績：用途別（2020年～2025年）
    • 世界のデュアルオレキシン受容体拮抗薬の売上の予測：用途別（2026年～2031年）
    • 世界のデュアルオレキシン受容体拮抗薬の売上の市場シェア：用途別（2020年～2031年）
  • 世界の収益：用途別
    • 世界のデュアルオレキシン受容体拮抗薬の収益の実績：用途別（2020年～2025年）
    • 世界のデュアルオレキシン受容体拮抗薬の収益の予測：用途別（2026年～2031年）
    • 世界のデュアルオレキシン受容体拮抗薬の収益の市場シェア：用途別（2020年～2031年）
  • 世界の価格：用途別
    • 世界のデュアルオレキシン受容体拮抗薬の価格：用途別（2020年～2025年）
    • 世界のデュアルオレキシン受容体拮抗薬の価格の予測：用途別（2026年～2031年）

第6章 米国・カナダ

  • 米国・カナダの市場規模：タイプ別
    • 米国・カナダのデュアルオレキシン受容体拮抗薬の売上：タイプ別（2020年～2031年）
    • 米国・カナダのデュアルオレキシン受容体拮抗薬の収益：タイプ別（2020年～2031年）
  • 米国・カナダの市場規模：用途別
    • 米国・カナダのデュアルオレキシン受容体拮抗薬の売上：用途別（2020年～2031年）
    • 米国・カナダのデュアルオレキシン受容体拮抗薬の収益：用途別（2020年～2031年）
  • 米国・カナダの市場規模：国別
    • 米国・カナダのデュアルオレキシン受容体拮抗薬の収益：国別（2020年・2024年・2031年）
    • 米国・カナダのデュアルオレキシン受容体拮抗薬の収益：国別（2020年～2031年）
    • 米国・カナダのデュアルオレキシン受容体拮抗薬の売上：国別（2020年～2031年）
    • 米国
    • カナダ

第7章 欧州

  • 欧州の市場規模：タイプ別
    • 欧州のデュアルオレキシン受容体拮抗薬の売上：タイプ別（2020年～2031年）
    • 欧州のデュアルオレキシン受容体拮抗薬の収益：タイプ別（2020年～2031年）
  • 欧州の市場規模：用途別
    • 欧州のデュアルオレキシン受容体拮抗薬の売上：用途別（2020年～2031年）
    • 欧州のデュアルオレキシン受容体拮抗薬の収益：用途別（2020年～2031年）

第8章 日本

  • 日本の市場規模：タイプ別
    • 日本のデュアルオレキシン受容体拮抗薬の売上：タイプ別（2020年～2031年）
    • 日本のデュアルオレキシン受容体拮抗薬の収益：タイプ別（2020年～2031年）
  • 日本の市場規模：用途別
    • 日本のデュアルオレキシン受容体拮抗薬の売上：用途別（2020年～2031年）
    • 日本のデュアルオレキシン受容体拮抗薬の収益：用途別（2020年～2031年）

第9章 争い

  • その他の地域の市場規模：タイプ別
    • その他の地域のデュアルオレキシン受容体拮抗薬の売上：タイプ別（2020年～2031年）
    • その他の地域のデュアルオレキシン受容体拮抗薬の収益：タイプ別（2020年～2031年）
  • その他の地域の市場規模：用途別
    • その他の地域のデュアルオレキシン受容体拮抗薬の売上：用途別（2020年～2031年）
    • その他の地域のデュアルオレキシン受容体拮抗薬の収益：用途別（2020年～2031年）

第10章 企業プロファイル

  • Merck
  • Eisal
  • Idorsia

第11章 産業チェーンと販売チャネルの分析

  • デュアルオレキシン受容体拮抗薬の産業チェーン分析
  • デュアルオレキシン受容体拮抗薬の主な原材料
    • 主な原材料
    • 原材料の主要サプライヤー
  • デュアルオレキシン受容体拮抗薬の生産方式とプロセス
  • デュアルオレキシン受容体拮抗薬の販売とマーケティング
    • デュアルオレキシン受容体拮抗薬の販売チャネル
    • デュアルオレキシン受容体拮抗薬の販売業者
  • デュアルオレキシン受容体拮抗薬の顧客

第12章 デュアルオレキシン受容体拮抗薬の市場力学

    • デュアルオレキシン受容体拮抗薬産業の動向
    • デュアルオレキシン受容体拮抗薬市場の促進要因
    • デュアルオレキシン受容体拮抗薬市場の課題
    • デュアルオレキシン受容体拮抗薬市場の抑制要因

第13章 世界のデュアルオレキシン受容体拮抗薬研究における主な調査結果

第14章 付録

図表

List of Tables

  • Table 1. Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
  • Table 2. Major Manufacturers of Suvorexant
  • Table 3. Major Manufacturers of Lemborexant
  • Table 4. Major Manufacturers of Daridorexant
  • Table 5. Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
  • Table 6. Global Dual Orexin Receptor Antagonist Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 7. Global Revenue by Region (2020-2025) & (US$ Million)
  • Table 8. Global Revenue by Region (2026-2031) & (US$ Million)
  • Table 9. Global Revenue Market Share by Region (2020-2025)
  • Table 10. Global Revenue Market Share by Region (2026-2031)
  • Table 11. Global Dual Orexin Receptor Antagonist Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (M Units)
  • Table 12. Global Dual Orexin Receptor Antagonist Sales by Region (2020-2025) & (M Units)
  • Table 13. Global Dual Orexin Receptor Antagonist Sales by Region (2026-2031) & (M Units)
  • Table 14. Global Sales Market Share by Region (2020-2025)
  • Table 15. Global Sales Market Share by Region (2026-2031)
  • Table 16. Global Dual Orexin Receptor Antagonist Sales by Manufacturers (2020-2025) & (M Units)
  • Table 17. Global Dual Orexin Receptor Antagonist Sales Share by Manufacturers (2020-2025)
  • Table 18. Global Dual Orexin Receptor Antagonist Revenue by Manufacturers (2020-2025) & (US$ Million)
  • Table 19. Global Dual Orexin Receptor Antagonist Revenue Market Share by Manufacturers (2020-2025)
  • Table 20. Global Key Players of Dual Orexin Receptor Antagonist, Industry Ranking, 2023 VS 2024 VS 2024
  • Table 21. Dual Orexin Receptor Antagonist Price by Manufacturers (2020-2025) & (US$/Unit)
  • Table 22. Global Dual Orexin Receptor Antagonist Manufacturers Market Concentration Ratio (CR3 and HHI)
  • Table 23. Global Dual Orexin Receptor Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dual Orexin Receptor Antagonist as of 2024)
  • Table 24. Global Key Manufacturers of Dual Orexin Receptor Antagonist, Manufacturing Base Distribution and Headquarters
  • Table 25. Global Key Manufacturers of Dual Orexin Receptor Antagonist, Product Offered and Application
  • Table 26. Global Key Manufacturers of Dual Orexin Receptor Antagonist, Date of Enter into This Industry
  • Table 27. Mergers & Acquisitions, Expansion Plans
  • Table 28. Global Dual Orexin Receptor Antagonist Sales by Type (2020-2025) & (M Units)
  • Table 29. Global Dual Orexin Receptor Antagonist Sales by Type (2026-2031) & (M Units)
  • Table 30. Global Sales Share by Type (2020-2025)
  • Table 31. Global Sales Share by Type (2026-2031)
  • Table 32. Global Dual Orexin Receptor Antagonist Revenue by Type (2020-2025) & (US$ Million)
  • Table 33. Global Dual Orexin Receptor Antagonist Revenue by Type (2026-2031) & (US$ Million)
  • Table 34. Global Revenue Share by Type (2020-2025)
  • Table 35. Global Revenue Share by Type (2026-2031)
  • Table 36. Dual Orexin Receptor Antagonist Price by Type (2020-2025) & (US$/Unit)
  • Table 37. Global Dual Orexin Receptor Antagonist Price Forecast by Type (2026-2031) & (US$/Unit)
  • Table 38. Global Dual Orexin Receptor Antagonist Sales by Application (2020-2025) & (M Units)
  • Table 39. Global Dual Orexin Receptor Antagonist Sales by Application (2026-2031) & (M Units)
  • Table 40. Global Sales Share by Application (2020-2025)
  • Table 41. Global Sales Share by Application (2026-2031)
  • Table 42. Global Dual Orexin Receptor Antagonist Revenue by Application (2020-2025) & (US$ Million)
  • Table 43. Global Dual Orexin Receptor Antagonist Revenue by Application (2026-2031) & (US$ Million)
  • Table 44. Global Revenue Share by Application (2020-2025)
  • Table 45. Global Revenue Share by Application (2026-2031)
  • Table 46. Dual Orexin Receptor Antagonist Price by Application (2020-2025) & (US$/Unit)
  • Table 47. Global Dual Orexin Receptor Antagonist Price Forecast by Application (2026-2031) & (US$/Unit)
  • Table 48. US & Canada Sales by Type (2020-2025) & (M Units)
  • Table 49. US & Canada Sales by Type (2026-2031) & (M Units)
  • Table 50. US & Canada Revenue by Type (2020-2025) & (US$ Million)
  • Table 51. US & Canada Revenue by Type (2026-2031) & (US$ Million)
  • Table 52. US & Canada Sales by Application (2020-2025) & (M Units)
  • Table 53. US & Canada Sales by Application (2026-2031) & (M Units)
  • Table 54. US & Canada Revenue by Application (2020-2025) & (US$ Million)
  • Table 55. US & Canada Revenue by Application (2026-2031) & (US$ Million)
  • Table 56. US & Canada Dual Orexin Receptor Antagonist Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 57. US & Canada Revenue by Country (2020-2025) & (US$ Million)
  • Table 58. US & Canada Revenue by Country (2026-2031) & (US$ Million)
  • Table 59. US & Canada Sales by Country (2020-2025) & (M Units)
  • Table 60. US & Canada Sales by Country (2026-2031) & (M Units)
  • Table 61. Europe Sales by Type (2020-2025) & (M Units)
  • Table 62. Europe Sales by Type (2026-2031) & (M Units)
  • Table 63. Europe Revenue by Type (2020-2025) & (US$ Million)
  • Table 64. Europe Revenue by Type (2026-2031) & (US$ Million)
  • Table 65. Europe Sales by Application (2020-2025) & (M Units)
  • Table 66. Europe Sales by Application (2026-2031) & (M Units)
  • Table 67. Europe Revenue by Application (2020-2025) & (US$ Million)
  • Table 68. Europe Revenue by Application (2026-2031) & (US$ Million)
  • Table 69. Japan Sales by Type (2020-2025) & (M Units)
  • Table 70. Japan Sales by Type (2026-2031) & (M Units)
  • Table 71. Japan Revenue by Type (2020-2025) & (US$ Million)
  • Table 72. Japan Revenue by Type (2026-2031) & (US$ Million)
  • Table 73. Japan Sales by Application (2020-2025) & (M Units)
  • Table 74. Japan Sales by Application (2026-2031) & (M Units)
  • Table 75. Japan Revenue by Application (2020-2025) & (US$ Million)
  • Table 76. Japan Revenue by Application (2026-2031) & (US$ Million)
  • Table 77. ROW Sales by Type (2020-2025) & (M Units)
  • Table 78. ROW Sales by Type (2026-2031) & (M Units)
  • Table 79. ROW Revenue by Type (2020-2025) & (US$ Million)
  • Table 80. ROW Revenue by Type (2026-2031) & (US$ Million)
  • Table 81. ROW Sales by Application (2020-2025) & (M Units)
  • Table 82. ROW Sales by Application (2026-2031) & (M Units)
  • Table 83. ROW Revenue by Application (2020-2025) & (US$ Million)
  • Table 84. ROW Revenue by Application (2026-2031) & (US$ Million)
  • Table 85. Merck Company Information
  • Table 86. Merck Description and Major Businesses
  • Table 87. Merck Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 88. Merck Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 89. Merck Recent Developments
  • Table 90. Eisal Company Information
  • Table 91. Eisal Description and Major Businesses
  • Table 92. Eisal Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 93. Eisal Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 94. Eisal Recent Developments
  • Table 95. Idorsia Company Information
  • Table 96. Idorsia Description and Major Businesses
  • Table 97. Idorsia Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 98. Idorsia Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 99. Idorsia Recent Developments
  • Table 100. Key Raw Materials Lists
  • Table 101. Raw Materials Key Suppliers Lists
  • Table 102. Distributors List
  • Table 103. Customers List
  • Table 104. Market Trends
  • Table 105. Market Drivers
  • Table 106. Market Challenges
  • Table 107. Market Restraints
  • Table 108. Research Programs/Design for This Report
  • Table 109. Key Data Information from Secondary Sources
  • Table 110. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Dual Orexin Receptor Antagonist Product Picture
  • Figure 2. Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Dual Orexin Receptor Antagonist Market Share by Type: 2024 & 2031
  • Figure 4. Suvorexant Product Picture
  • Figure 5. Lemborexant Product Picture
  • Figure 6. Daridorexant Product Picture
  • Figure 7. Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 8. Global Dual Orexin Receptor Antagonist Market Share by Application: 2024 & 2031
  • Figure 9. Hospital and Clinic
  • Figure 10. Retail Pharmacies
  • Figure 11. Other
  • Figure 12. Dual Orexin Receptor Antagonist Report Years Considered
  • Figure 13. Global Dual Orexin Receptor Antagonist Revenue, (US$ Million), 2020 VS 2024 VS 2031
  • Figure 14. Global Dual Orexin Receptor Antagonist Revenue (2020-2031) & (US$ Million)
  • Figure 15. Global Dual Orexin Receptor Antagonist Revenue by Region (2020-2031) (US$ Million)
  • Figure 16. Global Dual Orexin Receptor Antagonist Revenue Market Share by Region in Percentage: 2024 Versus 2031
  • Figure 17. Global Dual Orexin Receptor Antagonist Revenue Market Share by Region (2020-2031)
  • Figure 18. Global Dual Orexin Receptor Antagonist Sales (2020-2031) & (M Units)
  • Figure 19. Global Dual Orexin Receptor Antagonist Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (M Units)
  • Figure 20. Global Dual Orexin Receptor Antagonist Sales Market Share by Region (2020-2031)
  • Figure 21. US & Canada Dual Orexin Receptor Antagonist Sales YoY (2020-2031) & (M Units)
  • Figure 22. US & Canada Dual Orexin Receptor Antagonist Revenue YoY (2020-2031) & (US$ Million)
  • Figure 23. Europe Dual Orexin Receptor Antagonist Sales YoY (2020-2031) & (M Units)
  • Figure 24. Europe Dual Orexin Receptor Antagonist Revenue YoY (2020-2031) & (US$ Million)
  • Figure 25. Japan Dual Orexin Receptor Antagonist Sales YoY (2020-2031) & (M Units)
  • Figure 26. Japan Dual Orexin Receptor Antagonist Revenue YoY (2020-2031) & (US$ Million)
  • Figure 27. ROW Dual Orexin Receptor Antagonist Sales YoY (2020-2031) & (M Units)
  • Figure 28. ROW Dual Orexin Receptor Antagonist Revenue YoY (2020-2031) & (US$ Million)
  • Figure 29. Global Dual Orexin Receptor Antagonist Sales Share by Manufacturers (2024)
  • Figure 30. The Dual Orexin Receptor Antagonist Market Share of Top 2 Largest Manufacturers Around the World in 2024
  • Figure 31. Global Dual Orexin Receptor Antagonist Revenue Share by Manufacturers (2024)
  • Figure 32. The Top 2 Largest Manufacturers of Dual Orexin Receptor Antagonist in the World: Market Share by Dual Orexin Receptor Antagonist Revenue in 2024
  • Figure 33. Global Dual Orexin Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 34. Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2020-2031)
  • Figure 35. Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2020-2031)
  • Figure 36. Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2020-2031)
  • Figure 37. Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2020-2031)
  • Figure 38. US & Canada Dual Orexin Receptor Antagonist Sales Market Share by Type (2020-2031)
  • Figure 39. US & Canada Dual Orexin Receptor Antagonist Revenue Market Share by Type (2020-2031)
  • Figure 40. US & Canada Dual Orexin Receptor Antagonist Sales Market Share by Application (2020-2031)
  • Figure 41. US & Canada Dual Orexin Receptor Antagonist Revenue Market Share by Application (2020-2031)
  • Figure 42. US & Canada Dual Orexin Receptor Antagonist Revenue Share by Country (2020-2031)
  • Figure 43. US & Canada Dual Orexin Receptor Antagonist Sales Share by Country (2020-2031)
  • Figure 44. US Dual Orexin Receptor Antagonist Revenue (2020-2031) & (US$ Million)
  • Figure 45. Canada Dual Orexin Receptor Antagonist Revenue (2020-2031) & (US$ Million)
  • Figure 46. Europe Dual Orexin Receptor Antagonist Sales Market Share by Application (2022-2031)
  • Figure 47. Europe Dual Orexin Receptor Antagonist Revenue Market Share by Application (2022-2031)
  • Figure 48. Japan Dual Orexin Receptor Antagonist Sales Market Share by Type (2020-2031)
  • Figure 49. Japan Dual Orexin Receptor Antagonist Revenue Market Share by Type (2020-2031)
  • Figure 50. Japan Dual Orexin Receptor Antagonist Sales Market Share by Application (2020-2031)
  • Figure 51. Japan Dual Orexin Receptor Antagonist Revenue Market Share by Application (2020-2031)
  • Figure 52. ROW Dual Orexin Receptor Antagonist Sales Market Share by Application (2020-2031)
  • Figure 53. ROW Dual Orexin Receptor Antagonist Revenue Market Share by Application (2020-2031)
  • Figure 54. Value Chain
  • Figure 55. Channels of Distribution (Direct Vs Distribution)
  • Figure 56. Bottom-up and Top-down Approaches for This Report
  • Figure 57. Data Triangulation
  • Figure 58. Key Executives Interviewed
目次

The global Dual Orexin Receptor Antagonist market is projected to grow from US$ 670.85 million in 2024 to US$ 1,234.97 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.14% during the forecast period.

The United States & Canada market for Dual Orexin Receptor Antagonist is estimated to increase from $ 145.76 million in 2024 to reach $162.32 million by 2031, at a CAGR of 0.61% during the forecast period of 2025 through 2031.

The Japan market for Dual Orexin Receptor Antagonist is estimated to increase from $ 431.87 million in 2024 to reach $707.11 million by 2031, at a CAGR of 5.18% during the forecast period of 2025 through 2031.

The Europe market for Dual Orexin Receptor Antagonist is estimated to increase from $ 79.35 million in 2024 to reach $343.07 million by 2031, at a CAGR of 18.23% during the forecast period of 2025 through 2031.

The global key manufacturers of Dual Orexin Receptor Antagonist include Merck, Eisal, Idorsia, etc. In 2024, the global top two players had a share approximately 83.43% in terms of revenue.

Report Includes

This report presents an overview of global market for Dual Orexin Receptor Antagonist, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Dual Orexin Receptor Antagonist, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dual Orexin Receptor Antagonist, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dual Orexin Receptor Antagonist sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2024. Identification of the major stakeholders in the global Dual Orexin Receptor Antagonist market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Dual Orexin Receptor Antagonist sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Merck, Eisal, Idorsia, etc.

Market Segmentation

By Company

  • Merck
  • Eisal
  • Idorsia

Segment by Type

  • Suvorexant
  • Lemborexant
  • Daridorexant

Segment by Application

  • Hospital and Clinic
  • Retail Pharmacies
  • Other

Segment by Region

US & Canada

  • U.S.
  • Canada

Europe

Japan

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Dual Orexin Receptor Antagonist in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Dual Orexin Receptor Antagonist manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, and by Application, sales, and revenue for each segment.

Chapter 8: Japan by Type, and by Application, sales, and revenue for each segment.

Chapter 9: ROW by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dual Orexin Receptor Antagonist sales, revenue, price, gross margin, and recent development, etc.

Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 13: The main points and conclusions of the report.

Table of Contents

1 STUDY COVERAGE

  • 1.1 Dual Orexin Receptor Antagonist Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
    • 1.2.2 Suvorexant
    • 1.2.3 Lemborexant
    • 1.2.4 Daridorexant
  • 1.3 Market by Application
    • 1.3.1 Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
    • 1.3.2 Hospital and Clinic
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 EXECUTIVE SUMMARY

  • 2.1 Global Dual Orexin Receptor Antagonist Revenue Estimates and Forecasts 2020-2031
  • 2.2 Global Revenue by Region
    • 2.2.1 Global Dual Orexin Receptor Antagonist Revenue by Region: 2020 VS 2024 VS 2031
    • 2.2.2 Global Dual Orexin Receptor Antagonist Revenue by Region (2020-2031)
    • 2.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Region (2020-2031)
  • 2.3 Global Dual Orexin Receptor Antagonist Sales Estimates and Forecasts 2020-2031
  • 2.4 Global Sales by Region
    • 2.4.1 Global Dual Orexin Receptor Antagonist Sales by Region: 2020 VS 2024 VS 2031
    • 2.4.2 Global Dual Orexin Receptor Antagonist Sales by Region (2020-2031)
    • 2.4.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Region (2020-2031)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 Japan
  • 2.8 ROW

3 COMPETITION BY MANUFACTURERS

  • 3.1 Global Sales by Manufacturers
    • 3.1.1 Global Dual Orexin Receptor Antagonist Sales by Manufacturers (2020-2025)
    • 3.1.2 Global Dual Orexin Receptor Antagonist Sales Market Share by Manufacturers (2020-2025)
    • 3.1.3 Global Top 3 Largest Manufacturers of Dual Orexin Receptor Antagonist in 2024
  • 3.2 Global Revenue by Manufacturers
    • 3.2.1 Global Dual Orexin Receptor Antagonist Revenue by Manufacturers (2020-2025)
    • 3.2.2 Global Dual Orexin Receptor Antagonist Revenue Market Share by Manufacturers (2020-2025)
    • 3.2.3 Global Top 2 Companies by Dual Orexin Receptor Antagonist Revenue in 2024
  • 3.3 Global Key Players of Dual Orexin Receptor Antagonist, Industry Ranking, 2023 VS 2024
  • 3.4 Global Dual Orexin Receptor Antagonist Sales Price by Manufacturers (2020-2025)
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR3 and HHI)
    • 3.5.2 Global Dual Orexin Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Product Offered and Application
  • 3.8 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

  • 4.1 Global Sales by Type
    • 4.1.1 Global Dual Orexin Receptor Antagonist Historical Sales by Type (2020-2025)
    • 4.1.2 Global Dual Orexin Receptor Antagonist Forecasted Sales by Type (2026-2031)
    • 4.1.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2020-2031)
  • 4.2 Global Revenue by Type
    • 4.2.1 Global Dual Orexin Receptor Antagonist Historical Revenue by Type (2020-2025)
    • 4.2.2 Global Dual Orexin Receptor Antagonist Forecasted Revenue by Type (2026-2031)
    • 4.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2020-2031)
  • 4.3 Global Price by Type
    • 4.3.1 Global Dual Orexin Receptor Antagonist Price by Type (2020-2025)
    • 4.3.2 Global Dual Orexin Receptor Antagonist Price Forecast by Type (2026-2031)

5 MARKET SIZE BY APPLICATION

  • 5.1 Global Sales by Application
    • 5.1.1 Global Dual Orexin Receptor Antagonist Historical Sales by Application (2020-2025)
    • 5.1.2 Global Dual Orexin Receptor Antagonist Forecasted Sales by Application (2026-2031)
    • 5.1.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2020-2031)
  • 5.2 Global Revenue by Application
    • 5.2.1 Global Dual Orexin Receptor Antagonist Historical Revenue by Application (2020-2025)
    • 5.2.2 Global Dual Orexin Receptor Antagonist Forecasted Revenue by Application (2026-2031)
    • 5.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2020-2031)
  • 5.3 Global Price by Application
    • 5.3.1 Global Dual Orexin Receptor Antagonist Price by Application (2020-2025)
    • 5.3.2 Global Dual Orexin Receptor Antagonist Price Forecast by Application (2026-2031)

6 US & CANADA

  • 6.1 US & Canada Market Size by Type
    • 6.1.1 US & Canada Dual Orexin Receptor Antagonist Sales by Type (2020-2031)
    • 6.1.2 US & Canada Dual Orexin Receptor Antagonist Revenue by Type (2020-2031)
  • 6.2 US & Canada Market Size by Application
    • 6.2.1 US & Canada Dual Orexin Receptor Antagonist Sales by Application (2020-2031)
    • 6.2.2 US & Canada Dual Orexin Receptor Antagonist Revenue by Application (2020-2031)
  • 6.3 US & Canada Market Size by Country
    • 6.3.1 US & Canada Dual Orexin Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031
    • 6.3.2 US & Canada Dual Orexin Receptor Antagonist Revenue by Country (2020-2031)
    • 6.3.3 US & Canada Dual Orexin Receptor Antagonist Sales by Country (2020-2031)
    • 6.3.4 US
    • 6.3.5 Canada

7 EUROPE

  • 7.1 Europe Market Size by Type
    • 7.1.1 Europe Dual Orexin Receptor Antagonist Sales by Type (2020-2031)
    • 7.1.2 Europe Dual Orexin Receptor Antagonist Revenue by Type (2020-2031)
  • 7.2 Europe Market Size by Application
    • 7.2.1 Europe Dual Orexin Receptor Antagonist Sales by Application (2020-2031)
    • 7.2.2 Europe Dual Orexin Receptor Antagonist Revenue by Application (2020-2031)

8 JAPAN

  • 8.1 Japan Market Size by Type
    • 8.1.1 Japan Dual Orexin Receptor Antagonist Sales by Type (2020-2031)
    • 8.1.2 Japan Dual Orexin Receptor Antagonist Revenue by Type (2020-2031)
  • 8.2 Japan Market Size by Application
    • 8.2.1 Japan Dual Orexin Receptor Antagonist Sales by Application (2020-2031)
    • 8.2.2 Japan Dual Orexin Receptor Antagonist Revenue by Application (2020-2031)

9 ROW

  • 9.1 ROW Market Size by Type
    • 9.1.1 ROW Dual Orexin Receptor Antagonist Sales by Type (2020-2031)
    • 9.1.2 ROW Dual Orexin Receptor Antagonist Revenue by Type (2020-2031)
  • 9.2 ROW Market Size by Application
    • 9.2.1 ROW Dual Orexin Receptor Antagonist Sales by Application (2020-2031)
    • 9.2.2 ROW Dual Orexin Receptor Antagonist Revenue by Application (2020-2031)

10 CORPORATE PROFILE

  • 10.1 Merck
    • 10.1.1 Merck Company Information
    • 10.1.2 Merck Overview
    • 10.1.3 Merck Dual Orexin Receptor Antagonist Sales, Price, Revenue and Gross Margin (2020-2025)
    • 10.1.4 Merck Dual Orexin Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    • 10.1.5 Merck Recent Developments
  • 10.2 Eisal
    • 10.2.1 Eisal Company Information
    • 10.2.2 Eisal Overview
    • 10.2.3 Eisal Dual Orexin Receptor Antagonist Sales, Price, Revenue and Gross Margin (2020-2025)
    • 10.2.4 Eisal Dual Orexin Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    • 10.2.5 Eisal Recent Developments
  • 10.3 Idorsia
    • 10.3.1 Idorsia Company Information
    • 10.3.2 Idorsia Overview
    • 10.3.3 Idorsia Dual Orexin Receptor Antagonist Sales, Price, Revenue and Gross Margin (2020-2025)
    • 10.3.4 Idorsia Dual Orexin Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    • 10.3.5 Idorsia Recent Developments

11 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

  • 11.1 Dual Orexin Receptor Antagonist Industry Chain Analysis
  • 11.2 Dual Orexin Receptor Antagonist Key Raw Materials
    • 11.2.1 Key Raw Materials
    • 11.2.2 Raw Materials Key Suppliers
  • 11.3 Dual Orexin Receptor Antagonist Production Mode & Process
  • 11.4 Dual Orexin Receptor Antagonist Sales and Marketing
    • 11.4.1 Dual Orexin Receptor Antagonist Sales Channels
    • 11.4.2 Dual Orexin Receptor Antagonist Distributors
  • 11.5 Dual Orexin Receptor Antagonist Customers

12 DUAL OREXIN RECEPTOR ANTAGONIST MARKET DYNAMICS

    • 12.1.1 Dual Orexin Receptor Antagonist Industry Trends
    • 12.1.2 Dual Orexin Receptor Antagonist Market Drivers
    • 12.1.3 Dual Orexin Receptor Antagonist Market Challenges
    • 12.1.4 Dual Orexin Receptor Antagonist Market Restraints

13 KEY FINDINGS IN THE GLOBAL DUAL OREXIN RECEPTOR ANTAGONIST STUDY

14 APPENDIX

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
    • 14.1.2 Data Source
  • 14.2 Author Details
  • 14.3 Disclaimer 96